Icon Genetics Provides Technology For Possible Ebola Treatment

HALLE, GERMANY - AUGUST 14: A technician holds vials containing engineered DNA that will be introduced into the leaves of nicotiana benthamiana plants, which are a close relative of tobacco, in a lab at the facilities of Icon Genetics on August 14, 2014 in Halle, Germany. Icon Genetics has developed a process to produce proteins and enzymes via the nicotiana benthamiana plant that will be used in the production of antibodies for ZMapp, which is being heralded as a possible cure to the ebola virus. (Photo by Sean Gallup/Getty Images)